retatrutide phase 2 study results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a trial Retatrutide just delivered one of

Retatrutide helps the body lose weight in three ways

Conditions like obesity with diabetes, sleep apnea, or hypertension call for evidencebased medical care rather than a supplement experiment

Insulin users must plan exercise carefully, often reducing their insulin dose before planned physical activity to prevent exercise-induced hypoglycemia

Here, we find support for this hypothesis, in that our participants taking GLP1-RAs had a delayed rise in BrAC up to 20 min post alcohol consumption

And I'm so grateful

As the study did not involve any human participants, individual consent to participate was also not applicable